356 related articles for article (PubMed ID: 29799387)
1.
Alcaraz E; Garcia C; Papalia M; Vay C; Friedman L; Passerini de Rossi B
J Med Microbiol; 2018 Jul; 67(7):992-1002. PubMed ID: 29799387
[No Abstract] [Full Text] [Related]
2. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
4.
Alcaraz E; Centrón D; Camicia G; Quiroga MP; Di Conza J; Passerini de Rossi B
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258754
[No Abstract] [Full Text] [Related]
5. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
Kaur P; Gautam V; Tewari R
Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
[TBL] [Abstract][Full Text] [Related]
6. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
7. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
Jia W; Wang J; Xu H; Li G
Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
[TBL] [Abstract][Full Text] [Related]
8. Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim-sulfamethoxazole resistance.
Neela V; Rankouhi SZ; van Belkum A; Goering RV; Awang R
Int J Infect Dis; 2012 Aug; 16(8):e603-7. PubMed ID: 22698885
[TBL] [Abstract][Full Text] [Related]
9. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
[TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants.
Nicoletti M; Iacobino A; Prosseda G; Fiscarelli E; Zarrilli R; De Carolis E; Petrucca A; Nencioni L; Colonna B; Casalino M
Int J Med Microbiol; 2011 Jan; 301(1):34-43. PubMed ID: 20952251
[TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital.
Gülmez D; Hasçelik G
Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102
[TBL] [Abstract][Full Text] [Related]
12. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
13. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity.
Flores-Treviño S; Gutiérrez-Ferman JL; Morfín-Otero R; Rodríguez-Noriega E; Estrada-Rivadeneyra D; Rivas-Morales C; Llaca-Díaz JM; Camacho-Ortíz A; Mendoza-Olazarán S; Garza-González E
J Med Microbiol; 2014 Nov; 63(Pt 11):1524-1530. PubMed ID: 25165124
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic insights into virulence factors of nosocomial Stenotrophomonas maltophilia isolates collected in Bulgaria (2011-2022).
Strateva T; Trifonova A; Stratev A; Peykov S
Acta Microbiol Immunol Hung; 2023 Sep; 70(3):220-230. PubMed ID: 37405903
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
18. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
[TBL] [Abstract][Full Text] [Related]
19. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
20. Stenotrophomonas maltophilia strains isolated from a university hospital in Japan: genomic variability and antibiotic resistance.
Tanimoto K
J Med Microbiol; 2013 Apr; 62(Pt 4):565-570. PubMed ID: 23264453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
